KIMBERLY DAHLBERG: Open Payments
NPI 1376254953 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 36 payments from 9 companies in 2025. Trend: 2023 $123 · 2024 $64 · 2025 $1,139
Food & beverage: $944Education: $195
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $373 |
| Janssen Biotech, Inc. | 5 | $249 |
| GENZYME CORPORATION | 2 | $158 |
| LEO Pharma Inc. | 10 | $147 |
| ABBVIE INC. | 5 | $105 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
| Incyte Corporation | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: Bimzelx, TREMFYA, DUPIXENT, ANZUPGO, SKYRIZI, ADBRY, RINVOQ, JAKAFI.
Industry payments across NV — which companies pay providers there.
